These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 34894405)
1. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer. Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405 [TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
3. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer. Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517 [TBL] [Abstract][Full Text] [Related]
4. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
6. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
7. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
8. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome sequencing uncovers a three-long noncoding RNA signature in predicting breast cancer survival. Guo W; Wang Q; Zhan Y; Chen X; Yu Q; Zhang J; Wang Y; Xu XJ; Zhu L Sci Rep; 2016 Jun; 6():27931. PubMed ID: 27338266 [TBL] [Abstract][Full Text] [Related]
10. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
11. The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients. Ge X; Lei S; Wang P; Wang W; Wang W Sci Rep; 2024 Feb; 14(1):3500. PubMed ID: 38347041 [TBL] [Abstract][Full Text] [Related]
12. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature. Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954 [TBL] [Abstract][Full Text] [Related]
13. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma. Zou W; Wang Z; Wang F; Li L; Liu R; Hu M BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689 [TBL] [Abstract][Full Text] [Related]
14. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
16. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610 [TBL] [Abstract][Full Text] [Related]
17. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
18. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients. Zhang X; Zhang M; Zhang X; Zhu X; Wang J BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427 [TBL] [Abstract][Full Text] [Related]
19. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649 [No Abstract] [Full Text] [Related]
20. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy. Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]